ENST00000544049.2:c.-88dupC

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

The ENST00000544049.2(KCNJ3):​c.-88dupC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.44 ( 9877 hom., cov: 0)
Exomes 𝑓: 0.30 ( 4747 hom. )

Consequence

KCNJ3
ENST00000544049.2 5_prime_UTR

Scores

Not classified

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.896

Publications

3 publications found
Variant links:
Genes affected
KCNJ3 (HGNC:6264): (potassium inwardly rectifying channel subfamily J member 3) Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, is controlled by G-proteins and plays an important role in regulating heartbeat. It associates with three other G-protein-activated potassium channels to form a heteromultimeric pore-forming complex that also couples to neurotransmitter receptors in the brain and whereby channel activation can inhibit action potential firing by hyperpolarizing the plasma membrane. These multimeric G-protein-gated inwardly-rectifying potassium (GIRK) channels may play a role in the pathophysiology of epilepsy, addiction, Down's syndrome, ataxia, and Parkinson's disease. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, May 2012]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000544049.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.499 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000544049.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNJ3
NM_002239.4
MANE Select
c.-93_-92insC
upstream_gene
N/ANP_002230.1P48549-1
KCNJ3
NM_001260509.2
c.-93_-92insC
upstream_gene
N/ANP_001247438.1D2X9V0
KCNJ3
NM_001260510.2
c.-93_-92insC
upstream_gene
N/ANP_001247439.1D2XBF0

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNJ3
ENST00000544049.2
TSL:1
c.-88dupC
5_prime_UTR
Exon 1 of 2ENSP00000438410.1P48549-2
KCNJ3
ENST00000651198.1
c.-42-583dupC
intron
N/AENSP00000498639.1A0A494C0M7
ENSG00000287900
ENST00000803267.1
n.769dupG
non_coding_transcript_exon
Exon 1 of 4

Frequencies

GnomAD3 genomes
AF:
0.436
AC:
49747
AN:
114190
Hom.:
9876
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.274
Gnomad AMI
AF:
0.625
Gnomad AMR
AF:
0.457
Gnomad ASJ
AF:
0.446
Gnomad EAS
AF:
0.0423
Gnomad SAS
AF:
0.409
Gnomad FIN
AF:
0.586
Gnomad MID
AF:
0.346
Gnomad NFE
AF:
0.504
Gnomad OTH
AF:
0.411
GnomAD4 exome
AF:
0.295
AC:
21126
AN:
71610
Hom.:
4747
Cov.:
2
AF XY:
0.297
AC XY:
11595
AN XY:
39026
show subpopulations
African (AFR)
AF:
0.138
AC:
431
AN:
3134
American (AMR)
AF:
0.247
AC:
1409
AN:
5702
Ashkenazi Jewish (ASJ)
AF:
0.276
AC:
223
AN:
808
East Asian (EAS)
AF:
0.0215
AC:
105
AN:
4880
South Asian (SAS)
AF:
0.203
AC:
1648
AN:
8118
European-Finnish (FIN)
AF:
0.482
AC:
7055
AN:
14642
Middle Eastern (MID)
AF:
0.246
AC:
310
AN:
1260
European-Non Finnish (NFE)
AF:
0.301
AC:
9159
AN:
30380
Other (OTH)
AF:
0.293
AC:
786
AN:
2686
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.519
Heterozygous variant carriers
0
479
958
1437
1916
2395
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.436
AC:
49759
AN:
114240
Hom.:
9877
Cov.:
0
AF XY:
0.437
AC XY:
24008
AN XY:
54932
show subpopulations
African (AFR)
AF:
0.274
AC:
7269
AN:
26498
American (AMR)
AF:
0.457
AC:
5117
AN:
11208
Ashkenazi Jewish (ASJ)
AF:
0.446
AC:
1277
AN:
2866
East Asian (EAS)
AF:
0.0417
AC:
113
AN:
2710
South Asian (SAS)
AF:
0.409
AC:
1369
AN:
3350
European-Finnish (FIN)
AF:
0.586
AC:
4548
AN:
7758
Middle Eastern (MID)
AF:
0.348
AC:
85
AN:
244
European-Non Finnish (NFE)
AF:
0.504
AC:
28832
AN:
57226
Other (OTH)
AF:
0.412
AC:
653
AN:
1586
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1363
2727
4090
5454
6817
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
472
944
1416
1888
2360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.349
Hom.:
666
Asia WGS
AF:
0.212
AC:
737
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.90
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs5835535;
hg19: chr2-155555195;
COSMIC: COSV54531306;
COSMIC: COSV54531306;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.